GlassScriptPhysician profile
Matthew James Finnegan
NPI 1003845223
$31,796.49
in general payments reported to CMS, 2019-2025
40 companies · $2,062 in 2025
The $2,062 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,640 · 2020: $6,015 · 2021: $5,186 · 2022: $2,573 · 2023: $8,786 · 2024: $5,535 · 2025: $2,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,250 · Food and Beverage: $4,291 · Travel and Lodging: $3,581 · Entertainment: $244 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,250.00 |
| Food and Beverage | $4,291.21 |
| Travel and Lodging | $3,580.87 |
| Entertainment | $244.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,174.84 | 2019-2025 | Da Vinci Surgical System |
| Deroyal Industries, INC. | $10,350.98 | 2022-2024 | Prospera Pro Negative Pressure Wound Therapy Units, Pruventor Turnpro System, Prospera Negative Pressure Wound Therapy Units |
| Ethicon US, LLC | $1,113.05 | 2019-2023 | Harmonic, Echelon Flex, Surgicel Nu-Knit |
| Abbvie INC. | $715.96 | 2021-2025 | |
| Smith+Nephew, INC. | $689.44 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home, Pico 14 |
| Organogenesis INC. | $330.59 | 2019-2025 | Puraply Wound Matrix, Puraply Am |
| Davol INC. | $255.92 | 2019-2025 | Arista |
| Allergan, INC. | $177.25 | 2019 | |
| Stryker Corporation | $175.00 | 2022 | |
| Paratek Pharmaceuticals, INC. | $163.60 | 2020-2024 | Nuzyra |
| Abbott Laboratories | $145.88 | 2019 | |
| Surmodics, INC. | $136.36 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight |
| Phathom Pharmaceuticals, INC. | $134.86 | 2024 | Voquezna |
| Bard Peripheral Vascular, INC. | $134.24 | 2020-2023 | |
| Bard Access Systems, INC. | $126.62 | 2019 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $120.07 | 2025 | Epclusa |
| Coloplast Corp | $81.03 | 2022-2025 | |
| Kci USA, INC. | $79.23 | 2019-2021 | |
| Solventum Corporation | $73.46 | 2024-2025 | V.A.C. Veraflo, Prevena, V.A.C.Ulta |
| Melinta Therapeutics, LLC | $72.62 | 2019 | |
| Misonix INC | $70.25 | 2020-2021 | |
| Ascensia Diabetes Care US INC. | $67.96 | 2025 | |
| Acera Surgical, INC. | $54.00 | 2022-2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $44.14 | 2020-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Convatec INC. | $35.16 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $26.65 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $23.56 | 2019 | |
| Beta Bionics, INC. | $20.80 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Baxter Healthcare | $19.73 | 2019 | |
| Urgo Medical North America, LLC | $19.41 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ardelyx, INC. | $18.97 | 2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.84 | 2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $18.06 | 2025 | Farxiga |
| Corcept Therapeutics | $17.73 | 2025 | Korlym |
| Axsome Therapeutics, INC. | $16.97 | 2024 | Auvelity |
| Lundbeck LLC | $16.69 | 2024 | Rexulti |
| Medtronic, INC. | $16.21 | 2025 | Ligasure |
| Axonics, INC. | $14.38 | 2021 | |
| Becton, Dickinson and Company | $13.46 | 2019 | |
| Shire North American Group INC | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Finnegan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.